CVS insider filings
CVS HEALTH Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen CVS transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 23,855 shares, $2,001,315 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 23,855 shares @ $83.89 ($2,001,315) by Shah Prem S, filed 2026-11-06.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Shah Prem S — EVP and Group President | 1 | 1 leg · 23,855 sh · $2,001,315 | — | — |
| Heitsenrether Teresa A — Director | 1 | — | — | — |
Recent insider filings — CVS HEALTH Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 3 | Heitsenrether Teresa A — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-06 | 4 | Shah Prem S — EVP and Group President | Purchase (P): 23,855 @ $83.89 | EDGAR |
| 2026-06-29 | 4 | Clark James David — SVP, Cont & Chief Acct Officer | Tax withholding (F): 454 @ $90.98 | EDGAR |
| 2026-06-01 | 4 | Newman Brian — EVP, Chief Financial Officer | Tax withholding (F): 2,478 @ $90.98 | EDGAR |
| 2026-06-01 | 4 | Compton-Phillips Amy — EVP, Chief Medical Officer | Tax withholding (F): 7,618 @ $90.98 | EDGAR |
| 2026-05-22 | 4 | AGUIRRE FERNANDO — Director | Disposition to issuer (D): 30,437 @ $93.78 · Disposition to issuer (D): 1,563 @ $93.50 | EDGAR |
| 2026-05-21 | 4 | ROBBINS LARRY — Director | Sale (S): 1,983,387 @ $94.45 · Sale (S): 151 @ $95.18 · Sale (S): 797,628 @ $93.48 · Sale (S): 152,691 @ $94.81 · Sale (S): 66,881 @ $95.67 · Sale (S): 800 @ $96.28 · +2 more | EDGAR |
| 2026-05-15 | 4 | Balser Jeffrey R. — Director | Grant/award (A): 2,058 @ $97.15 | EDGAR |
| 2026-05-15 | 4 | Shulman Douglas H. — Director | Grant/award (A): 1,447.50 (derivative) @ $97.15 | EDGAR |
| 2026-05-15 | 4 | Norwalk Leslie V — Director | Grant/award (A): 1,447 @ $97.15 | EDGAR |
| 2026-05-15 | 4 | Mahoney Michael F — Director | Grant/award (A): 1,737.00 (derivative) @ $97.15 | EDGAR |
| 2026-05-15 | 4 | Finucane Anne A. — Director | Grant/award (A): 1,544.00 (derivative) @ $97.15 | EDGAR |
| 2026-05-15 | 4 | Gallina John E — Director | Grant/award (A): 1,447.50 (derivative) @ $97.15 | EDGAR |
| 2026-05-15 | 4 | SANSONE GUY P — Director | Grant/award (A): 1,447 @ $97.15 | EDGAR |
| 2026-05-15 | 4 | KIRBY J SCOTT — Director | Grant/award (A): 1,447 @ $97.15 | EDGAR |
| 2026-05-15 | 4 | DECOUDREAUX ALECIA A — Director | Grant/award (A): 1,447.50 (derivative) @ $97.15 | EDGAR |
| 2026-05-15 | 4 | ROBBINS LARRY — Director | Grant/award (A): 1,930.01 (derivative) @ $97.15 | EDGAR |
| 2026-05-15 | 4 | AGUIRRE FERNANDO — Director | Grant/award (A): 1,563 @ $97.15 | EDGAR |
| 2026-05-15 | 4 | BROWN C DAVID II — Director | Grant/award (A): 1,544 @ $97.15 | EDGAR |
| 2026-05-11 | 4 | Mandadi Tilak — EVP, Chief Exp & Tech Officer | Sale (S): 69,551 @ $89.58 | EDGAR |
| 2026-04-02 | 4 | Shah Prem S — EVP and Group President | Grant/award (A): 25,062 @ $71.82 · Tax withholding (F): 1,484 @ $72.49 · Grant/award (A): 161,676 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | Mandadi Tilak — EVP, Chief Exp & Tech Officer | Grant/award (A): 22,277 @ $71.82 · Tax withholding (F): 3,634 @ $72.49 · Grant/award (A): 143,712 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | Newman Brian — EVP, Chief Financial Officer | Grant/award (A): 19,493 @ $71.82 · Grant/award (A): 125,748 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | Clark James David — SVP, Cont & Chief Acct Officer | Grant/award (A): 11,138 @ $71.82 · Tax withholding (F): 3,262 @ $72.49 · Grant/award (A): 11,976 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | Compton-Phillips Amy — EVP, Chief Medical Officer | Grant/award (A): 5,569 @ $71.82 · Grant/award (A): 35,928 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | CAPOZZI HEIDI B — EVP and Chief People Officer | Grant/award (A): 10,025 @ $71.82 · Tax withholding (F): 1,334 @ $72.49 · Grant/award (A): 64,670 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | Khichi Samrat S. — EVP, CPO and General Counsel | Grant/award (A): 12,531 @ $71.82 · Tax withholding (F): 3,541 @ $72.49 · Grant/award (A): 80,838 (derivative) @ $71.82 | EDGAR |
| 2026-04-02 | 4 | Joyner J. David — President, CEO and Chair, Director | Grant/award (A): 86,326 @ $71.82 · Tax withholding (F): 8,029 @ $72.49 | EDGAR |
| 2026-04-02 | 4 | Nelson Steven H — EVP and President, Aetna | Grant/award (A): 22,277 @ $71.82 · Tax withholding (F): 2,432 @ $72.49 · Grant/award (A): 143,712 (derivative) @ $71.82 | EDGAR |
| 2026-03-20 | 4 | Gallina John E — Director | Grant/award (A): 582 @ $71.86 | EDGAR |
| 2026-03-02 | 4 | Khichi Samrat S. — EVP, CPO and General Counsel | Tax withholding (F): 7,886 @ $79.60 | EDGAR |
| 2026-03-02 | 4 | Joyner J. David — President and CEO, Director | Tax withholding (F): 1,944 @ $79.90 | EDGAR |
| 2026-01-27 | 4 | Nelson Steven H — EVP and President, Aetna | Purchase (P): 24 @ $53.70 | EDGAR |
| 2026-01-05 | 4 | Shah Prem S — EVP and Group President | Tax withholding (F): 247 @ $80.13 | EDGAR |
| 2025-12-02 | 4 | Mandadi Tilak — EVP, Chief Exp & Tech Officer | Tax withholding (F): 6,575 @ $80.36 | EDGAR |
| 2025-12-02 | 4 | Clark James David — SVP, Cont & Chief Acct Officer | Tax withholding (F): 220 @ $79.10 | EDGAR |
| 2025-12-02 | 4 | CAPOZZI HEIDI B — EVP and Chief People Officer | Tax withholding (F): 9,470 @ $80.36 | EDGAR |
| 2025-12-02 | 4 | FARAH ROGER N — Director | Tax withholding (F): 9,748 @ $80.36 | EDGAR |
| 2025-11-21 | 4 | Balser Jeffrey R. — Director | Grant/award (A): 1,775 @ $76.04 | EDGAR |
| 2025-11-21 | 4 | Shulman Douglas H. — Director | Grant/award (A): 1,652 @ $76.04 | EDGAR |
| 2025-11-21 | 4 | Norwalk Leslie V — Director | Grant/award (A): 1,652 @ $76.04 | EDGAR |
| 2025-11-21 | 4 | Mahoney Michael F — Director | Grant/award (A): 2,021.96 (derivative) @ $76.04 | EDGAR |
| 2025-11-21 | 4 | Finucane Anne A. — Director | Grant/award (A): 591 @ $76.04 · Grant/award (A): 1,775.38 (derivative) @ $76.04 | EDGAR |
| 2025-11-21 | 4 | SANSONE GUY P — Director | Grant/award (A): 1,652 @ $76.04 | EDGAR |
| 2025-11-21 | 4 | KIRBY J SCOTT — Director | Grant/award (A): 1,652 @ $76.04 | EDGAR |
| 2025-11-21 | 4 | DECOUDREAUX ALECIA A — Director | Grant/award (A): 1,652.09 (derivative) @ $76.04 | EDGAR |
| 2025-11-21 | 4 | ROBBINS LARRY — Director | Grant/award (A): 2,202.79 (derivative) @ $76.04 | EDGAR |
| 2025-11-21 | 4 | AGUIRRE FERNANDO — Director | Grant/award (A): 1,800 @ $76.04 | EDGAR |
| 2025-11-21 | 4 | BROWN C DAVID II — Director | Grant/award (A): 1,775 @ $76.04 | EDGAR |
| 2025-10-14 | 4 | CAPOZZI HEIDI B — EVP and Chief People Officer | Purchase (P): 35 @ $56.47 · Purchase (P): 10 @ $62.24 · Purchase (P): 35 @ $56.85 | EDGAR |
Recent 8-K events — CVS HEALTH Corp
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CVS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs